Korean Circulation Journal

  • 제48권9호
  • /
  • Pages.767-777
  • /
  • 2018
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Coronary Artery Vasospasm

  • Song, Jae-Kwan (Department of Cardiology, Asan Medical Center Heart Institute, University of Ulsan College of Medicine)
  • 투고 : 2018.06.29
  • 심사 : 2018.07.31
  • 발행 : 2018.09.30
⟨ 이전 논문 다음 논문 ⟩

초록

Coronary artery vasospasm (CVS) is an important mechanism of myocardial ischemia and produces any of the manifestations of coronary artery disease from silent myocardial ischemia, to effort-induced angina and variant angina, to acute coronary syndrome including myocardial infarction or sudden cardiac death. The pathogenesis, characteristic clinical features, diagnosis, and treatment of CVS are summarized. Emphasis is placed on correct diagnosis of CVS using pharmacological spasm provocation test, either during coronary angiography or with echocardiographic monitoring of ventricular wall motion. Current underutilization of pharmacologic provocative test at the time of coronary angiography cannot be justified, as there is no evidence supporting that the incidence of CVS is declining. Physicians' vigilance for objective documentation of CVS is necessary for appropriate management of patients with various clinical presentations of ischemic heart disease.

키워드

참고문헌

  1. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. Angina pectoris. I. A variant form of angina pectoris; preliminary report. Am J Med 1959;27:375-88. https://doi.org/10.1016/0002-9343(59)90003-8
  2. Oliva PB, Potts DE, Pluss RG. Coronary arterial spasm in Prinzmetal angina. Documentation by coronary arteriography. N Engl J Med 1973;288:745-51. https://doi.org/10.1056/NEJM197304122881501
  3. Maseri A. Louis F. Bishop lecture. Role of coronary artery spasm in symptomatic and silent myocardial ischemia. J Am Coll Cardiol 1987;9:249-62. https://doi.org/10.1016/S0735-1097(87)80372-8
  4. Heupler FA Jr, Proudfit WL, Razavi M, Shirey EK, Greenstreet R, Sheldon WC. Ergonovine maleate provocative test for coronary arterial spasm. Am J Cardiol 1978;41:631-40. https://doi.org/10.1016/0002-9149(78)90810-X
  5. Yasue H, Horio Y, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-63. https://doi.org/10.1161/01.CIR.74.5.955
  6. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987;75:577-82. https://doi.org/10.1161/01.CIR.75.3.577
  7. Park SW, Park SJ, Kim JJ, Song JK, Seong IW, Lee JK. A comparative study of acetylcholine and ergonovine provocative test in patients with chest pain syndrome with normal or near normal coronary arteriograms. Korean Circ J 1991;21:842-8. https://doi.org/10.4070/kcj.1991.21.5.842
  8. Zaya M, Mehta PK, Merz NB. Provocative testing for coronary reactivity and spasm. J Am Coll Cardiol 2014;63:103-9. https://doi.org/10.1016/j.jacc.2013.10.038
  9. MacAlpin RN. Some observations on and controversies about coronary arterial spasm. Int J Cardiol 2015;181:389-98. https://doi.org/10.1016/j.ijcard.2014.12.047
  10. Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. Eur Heart J 2017;38:2565-8.
  11. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2012;60:e44-164. https://doi.org/10.1016/j.jacc.2012.07.013
  12. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61:e179-347.
  13. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J 2014;78:2779-801. https://doi.org/10.1253/circj.CJ-66-0098
  14. Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978;58:56-62. https://doi.org/10.1161/01.CIR.58.1.56
  15. Waters DD, Szlachcic J, Bonan R, Miller DD, Dauwe F, Theroux P. Comparative sensitivity of exercise, cold pressor and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 1983;67:310-5. https://doi.org/10.1161/01.CIR.67.2.310
  16. Bertrand ME, LaBlanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306. https://doi.org/10.1161/01.CIR.65.7.1299
  17. Takagi Y, Yasuda S, Takahashi J, et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J 2013;34:258-67. https://doi.org/10.1093/eurheartj/ehs199
  18. Song JK, Park SW, Kim JJ, et al. Values of intravenous ergonovine test with two-dimensional echocardiography for diagnosis of coronary artery spasm. J Am Soc Echocardiogr 1994;7:607-15. https://doi.org/10.1016/S0894-7317(14)80083-7
  19. Song JK, Lee SJ, Kang DH, et al. Ergonovine echocardiography as a screening test for diagnosis of vasospastic angina before coronary angiography. J Am Coll Cardiol 1996;27:1156-61. https://doi.org/10.1016/0735-1097(95)00590-0
  20. Djordjevic-Dikic A, Varga A, Rodriguez O, et al. Safety of ergotamine-ergic pharmacologic stress echocardiography for vasospasm testing in the echo lab: 14 year experience on 478 tests in 464 patients. Cardiologia 1999;44:901-6.
  21. Song JK, Park SW, Kang DH, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol 2000;35:1850-6. https://doi.org/10.1016/S0735-1097(00)00646-X
  22. Buxton A, Goldberg S, Hirshfeld JW, et al. Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol 1980;46:329-34. https://doi.org/10.1016/0002-9149(80)90080-6
  23. Nesto RW, Kowalchuck GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987;59:23C-30C. https://doi.org/10.1016/0002-9149(87)90192-5
  24. Yasue H, Takizawa A, Nagao M, et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988;78:1-9. https://doi.org/10.1161/01.CIR.78.1.1
  25. Ahn JM, Lee KH, Yoo SY, et al. Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol 2016;68:137-45. https://doi.org/10.1016/j.jacc.2016.04.050

피인용 문헌

  1. Effect of sarpogrelate and high‐dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study vol.42, pp.10, 2018, https://doi.org/10.1002/clc.23239
  2. Diagnostic Utility and Pathogenic Role of Circulating MicroRNAs in Vasospastic Angina vol.9, pp.5, 2020, https://doi.org/10.3390/jcm9051313
  3. Diagnostic and Prognostic Value of Ergonovine Echocardiography for Noninvasive Diagnosis of Coronary Vasospasm vol.13, pp.9, 2018, https://doi.org/10.1016/j.jcmg.2020.03.008
  4. Coronary vasospasm: A narrative review vol.13, pp.9, 2021, https://doi.org/10.4330/wjc.v13.i9.456
  5. Multivessel coronary artery vasospasm masquerading as surgical coronary atherosclerotic disease vol.36, pp.10, 2021, https://doi.org/10.1111/jocs.15866